Polar Capital Holdings PLC Jazz Pharmaceuticals PLC Transaction History

Polar Capital Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $14.2 Million - $16.9 Million	-100,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $32.4 Million - $40.2 Million	-250,000 Reduced 71.43%	100,000 $15.6 Million
Q4 2021 Feb 14, 2022	BUY	$119.87 - $145.67 $8.99 Million - $10.9 Million	75,000 Added 27.27%	350,000 $44.6 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $16.1 Million - $23.1 Million	125,000 Added 83.33%	275,000 $35.8 Million
Q2 2021 Aug 16, 2021	BUY	$160.2 - $186.42 $4 Million - $4.66 Million	25,000 Added 20.0%	150,000 $26.6 Million
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $7.51 Million - $8.68 Million	50,000 Added 66.67%	125,000 $20.5 Million
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $10.6 Million - $12.4 Million	75,000 New	75,000 $12.4 Million

514

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.8B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.